Lifestance Short Long Term Debt Total from 2010 to 2026
| LFST Stock | USD 6.64 -0.09 -1.34% |
Short and Long Term Debt Total | First Reported 2020-12-31 | Previous Quarter 473.6 M | Current Value 194.1 M | Quarterly Volatility 145.1 M |
Lifestance | Short Long Term Debt Total | Build AI portfolio with Lifestance Stock |
Latest Lifestance Health's Short Long Term Debt Total Growth Pattern
| Short Long Term Debt Total | 10 Years Trend |
|
Short Long Term Debt Total |
| Timeline |
Lifestance Short Long Term Debt Total Regression Statistics
| Arithmetic Mean | 196,739,652 | |
| Geometric Mean | 143,637,306 | |
| Coefficient Of Variation | 85.75 | |
| Mean Deviation | 142,929,391 | |
| Median | 79,314,000 | |
| Standard Deviation | 168,710,769 | |
| Sample Variance | 28463.3T | |
| Range | 431.7M | |
| R-Value | 0.74 | |
| Mean Square Error | 13918.8T | |
| R-Squared | 0.54 | |
| Significance | 0.0008 | |
| Slope | 24,586,325 | |
| Total Sum of Squares | 455413.2T |
Lifestance Short Long Term Debt Total History
Stock Overview, Methodology & Data Sources
Methodology
Unless otherwise specified, financial data for Lifestance Health Group is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Lifestance (USA Stocks:LFST) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Our reporting uses public filings and market reference sources and institutional disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Normalization procedures may introduce minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Lifestance Health Group may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial BoardThematic Opportunities
Explore Investment Opportunities
Additional Tools for Lifestance Stock Analysis
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |